STOCK TITAN

DIH Holdings US Stock Price, News & Analysis

DHAI NASDAQ

Company Description

Overview

DIH Holdings US, Inc. is a global provider of innovative robotic rehabilitation devices, integrating virtual reality with advanced clinical insights to deliver interactive and effective rehabilitative care. The company leverages state-of-the-art robotic technology and immersive visual stimulation to assist patients with walking, balance, and upper limb impairments, providing them a pathway to improved function and enhanced quality of life. Its solutions are designed for use in clinical research and intensive therapy environments, ensuring that healthcare professionals have access to devices that promote intensive rehabilitation and measurable clinical outcomes.

Technology and Product Integration

At its core, the company develops and markets robotic devices that utilize interactive visual stimulation. By combining robotics with virtual reality elements, DIH Holdings US offers a unique product suite tailored to meet the demanding requirements of physical rehabilitation programs. These devices are designed to engage patients actively, facilitating natural movement patterns and providing real-time feedback that is crucial for recovery. Their technology supports a range of rehabilitative therapies, particularly for individuals experiencing challenges with ambulation, balance, and motor function in the arms and hands.

Business Model and Revenue Generation

The company's revenue model primarily stems from the sale of its cutting-edge rehabilitation devices to a diverse customer base that includes hospitals, specialized rehabilitation centers, academic research institutions, and clinical laboratories. By continuously innovating and expanding its product offerings, DIH Holdings US addresses the needs of a fragmented industry traditionally reliant on manual processes. Its strategic approach involves not only providing hardware solutions but also integrating software tools that facilitate data collection, performance tracking, and enhanced clinical decision-making.

Market Position and Global Reach

DIH Holdings US holds a significant presence in the global healthcare and rehabilitation technology market. The company competes in a niche segment characterized by complex clinical requirements and the need for precise, technology-driven solutions. By operating in multiple regions—including Europe, the Americas, and Asia—DIH has successfully positioned itself as a credible innovator in a landscape where advanced, interactive rehabilitation solutions are increasingly in demand. This widespread geographic footprint speaks to its ability to meet diverse market needs and regulatory standards across different territories.

Competitive Landscape and Industry Differentiation

The competitive environment in which DIH Holdings US operates features a variety of providers, ranging from traditional medical device manufacturers to niche technology companies specializing in robotic rehabilitation. What sets DIH apart is its commitment to blending robotics with immersive virtual reality technology. This multifaceted approach enables a deeper level of patient engagement and more rigorous clinical assessments during rehabilitation, thereby offering greater therapeutic benefits compared to conventional methods. Its focus on integrating technology with clinical practice has led to a robust portfolio that addresses both patient recovery and clinical research needs.

Clinical Impact and Research Integration

DIH Holdings US is also recognized for its contribution to clinical research. The interactive nature of its devices provides researchers with a dynamic tool for studying rehabilitative methods, utilizing real-time data to assess patient outcomes and therapy effectiveness. The company’s solutions are designed to support a range of clinical protocols, enabling extensive research studies and contributing to the broader body of knowledge in physical rehabilitation and neuro-motor recovery. This dual focus on therapy and research reinforces its role as a transformative player in the industry.

Operational Excellence and Innovation

Consistent with its mission to "Deliver Inspiration & Health," DIH Holdings US emphasizes continuous improvement and operational efficiency. The company adopts a meticulous approach to product development, ensuring that every device meets stringent quality standards and delivers reliable performance in demanding clinical environments. Its operations are characterized by cross-functional collaboration among experts in robotics, software engineering, clinical research, and rehabilitation therapy. This synergy not only enhances device functionality but also solidifies its reputation for technological excellence and trustworthiness among healthcare providers.

Summary

In summary, DIH Holdings US stands out as a transformative force in the rehabilitation technology market. By merging advanced robotics and virtual reality into a coherent, clinically integrated product line, it provides significant value throughout the rehabilitative process. Whether facilitating rigorous clinical research or enabling intensive functional rehabilitation, the company remains focused on empowering patients while driving innovation within a traditionally fragmented industry.

Stock Performance

$0.1678
+1.02%
+0.00
Last updated: April 25, 2025 at 06:49
-87.51 %
Performance 1 year
$8.3M
Market Cap
47.3M
Shares outstanding

SEC Filings

No SEC filings available for DIH Holdings US.

Financial Highlights

$15,094,000
Revenue (TTM)
-$3,728,000
Net Income (TTM)
-$0.11
Diluted EPS (TTM)
$686,000
Operating Cash Flow
-24.70%
Net Profit Margin
-18.19%
Oper. Profit Margin

Upcoming Events

Frequently Asked Questions

What is the current stock price of DIH Holdings US (DHAI)?

The current stock price of DIH Holdings US (DHAI) is $0.1661 as of April 24, 2025.

What is the market cap of DIH Holdings US (DHAI)?

The market cap of DIH Holdings US (DHAI) is approximately 8.3M.

What is the revenue (TTM) of DIH Holdings US (DHAI) stock?

The trailing twelve months (TTM) revenue of DIH Holdings US (DHAI) is $15,094,000.

What is the net income of DIH Holdings US (DHAI)?

The trailing twelve months (TTM) net income of DIH Holdings US (DHAI) is -$3,728,000.

What is the earnings per share (EPS) of DIH Holdings US (DHAI)?

The diluted earnings per share (EPS) of DIH Holdings US (DHAI) is -$0.11 on a trailing twelve months (TTM) basis.

What is the operating cash flow of DIH Holdings US (DHAI)?

The operating cash flow of DIH Holdings US (DHAI) is $686,000.

What is the profit margin of DIH Holdings US (DHAI)?

The net profit margin of DIH Holdings US (DHAI) is -24.70%.

What is the operating margin of DIH Holdings US (DHAI)?

The operating profit margin of DIH Holdings US (DHAI) is -18.19%.

What is the gross margin of DIH Holdings US (DHAI)?

The gross profit margin of DIH Holdings US (DHAI) is 47.94%.

What is the current ratio of DIH Holdings US (DHAI)?

The current ratio of DIH Holdings US (DHAI) is 0.51, indicating the company's ability to pay short-term obligations.

What is the gross profit of DIH Holdings US (DHAI)?

The gross profit of DIH Holdings US (DHAI) is $7,236,000 on a trailing twelve months (TTM) basis.

What is the operating income of DIH Holdings US (DHAI)?

The operating income of DIH Holdings US (DHAI) is -$2,746,000.

What is the core focus of DIH Holdings US?

DIH Holdings US specializes in developing advanced robotic rehabilitation devices that integrate virtual reality to enhance clinical research and intensive functional therapy for patients with mobility impairments.

How do DIH Holdings US devices benefit patients?

Their devices use interactive visual stimulation combined with robotic technology to facilitate improved walking, balance, and upper limb function, enabling personalized, intensive rehabilitation programs.

What is the primary business model of the company?

The company generates revenue through the sale and integration of its advanced rehabilitation devices to hospitals, rehabilitation centers, and research institutions, while supporting clinical research and therapy optimization.

How does DIH Holdings US stand out in the rehabilitation technology market?

DIH distinguishes itself by blending robotics and virtual reality to create interactive, clinically integrated rehab solutions, fostering higher patient engagement and more precise clinical outcomes.

In which global markets does DIH Holdings US operate?

DIH Holdings US has established a significant presence in key regions including Europe, the Americas, and Asia, allowing it to address diverse clinical needs and regulatory environments globally.

What role does clinical research play in the company’s operations?

The company’s devices support extensive clinical research by providing real-time data and interactive therapy tools that help validate rehabilitative methods and improve patient outcomes.

Who are the likely customers for DIH Holdings US's products?

The company serves a wide range of customers including hospitals, specialized rehabilitation centers, academic institutions, and clinical laboratories that are focused on advanced therapeutic and research solutions.

How does DIH Holdings US ensure the quality and reliability of its devices?

By emphasizing operational efficiency, cross-disciplinary collaboration, and rigorous quality control in product development, the company ensures its devices perform reliably under demanding clinical conditions.